Projects per year
Fingerprint
Dive into the research topics where Jihad Snobre is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
Omics Data Integration to Predict Drug Resistance in Mycobacterium tuberculosis
Snobre, J. (PhD Student), de Jong, B. (Promotor), Buyl, R. (Promotor) & Tzfadia, O. (Promotor)
27/04/22 → 5/09/25
Project: PhD-project
Research output
-
Bedaquiline resistance in Mycobacterium tuberculosis: mechanisms and preventive strategies
Snobre, J., 5-Sept-2025, Brussel: Vrije Universiteit Brussel (VUB). 204 p.Research output: Thesis › Doctoral dissertation - Doctoral dissertation
-
High-dose amikacin in the first week of all-oral rifampicin-resistant TB treatment is safe: a single-arm trial
Snobre, J., Gasana, J., Decroo, T., Mucyo, Y., Jacobs, B. K. M., Rigouts, L., Martin, I. C., Herssens, N., Hakizayezu, F., Ntihumbya, J. B., Kilibazayire, A., de Viron, E., Runyambo, D., Ndayishimiye, C., Merle, C. S., Muvunyi, C. M., Migambi, P., Sturkenboom, M. G. G., de Jong, B. C. & Ngabonziza, J. C. S., Nov-2025, In: IJTLD open. 2, 11, p. 655-661 7 p.Research output: Contribution to journal › A1: Peer-reviewed journal articles › peer-review
Open Access -
Reply to Schön et al., "Quality control and considering systematic MIC shifts are key when evaluating the role of mmpR5 (Rv0678) frameshifts in bedaquiline resistance"
Snobre, J., Meehan, C., Mulders, W., Rigouts, L., Buyl, R., de Jong, B., Van Rie, A. & Tzfadia, O., Oct-2025, In: Antimicrobial Agents and Chemotherapy. 69, 10, 3 p., e00317-25.Research output: Contribution to journal › Letter › peer-review
Open Access -
Frameshift mutations in the mmpR5 gene can have a bedaquiline-susceptible phenotype by retaining a protein structure and function similar to wild-type Mycobacterium tuberculosis
Snobre, J., Meehan, C., Mulders, W., Rigouts, L., Buyl, R., de Jong, B., Van Rie, A. & Tzfadia, O., 2024, In: Antimicrobial Agents and Chemotherapy. 68, 12, 15 p.Research output: Contribution to journal › A1: Peer-reviewed journal articles › peer-review
Open Access -
Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trial
Snobre, J., Gasana, J., Ngabonziza, J., Cuella-Martin, I., Rigouts, L., Jacobs, B., de Viron, E., Herssens, N., Ntihumby, J., Klibazayre, A., Ndayishimiye, C., Van Deun, A., Affolabi, D., Merle, C., Muvunyi, C., Sturkenboom, M., Migambi, P., de Jong, B., Mucyo, Y. & Decroo, T., 2024, In: BMJ Open. 14, 7, 9 p., e078379.Research output: Contribution to journal › A1: Peer-reviewed journal articles › peer-review
Open Access